FAS and lung carcinoma: However, it has been shown that FAS inhibitors, such as orlistat and cerulenin, have produced severe side effects in mice with tumor model [37,38], and stable FAS-silencing lung cancer A549 cells has been found to unexpectedly increase cell migration and lung metastasis in vivo [39].